{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:08:03Z","timestamp":1777396083142,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:p>Background: APOE4 is the strongest risk factor for Alzheimer\u2019s disease (AD). However, limited information is currently available on APOE4 and the pathological role of plasma apolipoprotein E (ApoE) 4 remains unclear. Objective: The aims of the present study were to measure plasma levels of total ApoE (tE), ApoE2, ApoE3, and ApoE4 using mass spectrometry and elucidate the relationships between plasma ApoE and blood test items. Methods: We herein examined plasma levels of tE, ApoE2, ApoE3, and ApoE4 in 498 subjects using liquid chromatograph-mass spectrometry (LC-MS\/MS). Results: Among 498 subjects, mean age was 60 years and 309 were female. tE levels were distributed as ApoE2\/E3\u200a=\u200aApoE2\/E4 &gt;ApoE3\/E3\u200a=\u200aApoE3\/E4 &gt;ApoE4\/E4. In the heterozygous group, ApoE isoform levels were distributed as ApoE2 &gt;ApoE3 &gt;ApoE4. ApoE levels were not associated with aging, the plasma amyloid-\u03b2 (A\u03b2) 40\/42 ratio, or the clinical diagnosis of AD. Total cholesterol levels correlated with the level of each ApoE isoform. ApoE2 levels were associated with renal function, ApoE3 levels with low-density lipoprotein cholesterol and liver function, and ApoE4 levels with triglycerides, high-density lipoprotein cholesterol, body weight, erythropoiesis, and insulin metabolism. Conclusion: The present results suggest the potential of LC-MS\/MS for the phenotyping and quantitation of plasma ApoE. Plasma ApoE levels are regulated in the order of ApoE2 &gt;ApoE3 &gt;ApoE4 and are associated with lipids and multiple metabolic pathways, but not directly with aging or AD biomarkers. The present results provide insights into the multiple pathways by which peripheral ApoE4 influences the progression of AD and atherosclerosis.<\/jats:p>","DOI":"10.3233\/jad-220996","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T12:33:07Z","timestamp":1679661187000},"page":"333-348","source":"Crossref","is-referenced-by-count":5,"title":["Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma A\u03b240\/42 Ratio as a Biomarker of Amyloid-\u03b2 Amyloidosis in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"93","author":[{"given":"Takumi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan"},{"name":"Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kawarabayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan"},{"name":"Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan"},{"name":"Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ueda","sequence":"additional","affiliation":[{"name":"Bioanalysis Department, LSI Medience Corporation, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Bioanalysis Department, LSI Medience Corporation, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Bioanalysis Department, LSI Medience Corporation, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Nakaji","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Takatama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Shoji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan"},{"name":"Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan"},{"name":"Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220996_ref1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220996_ref2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-220996_ref3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: From cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.3233\/JAD-220996_ref4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-220996_ref5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-220996_ref6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jamaneurol.2017.4325","article-title":"Association of beta-amyloid and apolipoprotein E epsilon4 with memory decline in preclinical Alzheimer disease","volume":"75","author":"Lim","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220996_ref7","doi-asserted-by":"crossref","first-page":"e2414","DOI":"10.1212\/WNL.0000000000011883","article-title":"Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer disease","volume":"96","author":"Qian","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-220996_ref8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: Advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220996_ref9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220996_ref10","doi-asserted-by":"crossref","first-page":"158980","DOI":"10.1016\/j.bbalip.2021.158980","article-title":"Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-beta","volume":"1866","author":"Chai","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.3233\/JAD-220996_ref11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.3233\/JAD-220996_ref12","doi-asserted-by":"crossref","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-220996_ref13","doi-asserted-by":"crossref","first-page":"134306","DOI":"10.1016\/j.neulet.2019.134306","article-title":"Peripheral versus central nervous system APOE in Alzheimer\u2019s disease: Interplay across the blood-brain barrier","volume":"708","author":"Chernick","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220996_ref14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/pr401060x","article-title":"Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms","volume":"13","author":"Martinez-Morillo","year":"2014","journal-title":"J Proteome Res"},{"key":"10.3233\/JAD-220996_ref15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2015.12.020","article-title":"Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing","volume":"454","author":"Hirtz","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-220996_ref16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","article-title":"Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls","volume":"127","author":"Mart\u00ednez-Morillo","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220996_ref17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.euprot.2015.07.012","article-title":"Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"8","author":"Rezeli","year":"2015","journal-title":"EuPA Open Proteomics"},{"key":"10.3233\/JAD-220996_ref18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-020-00585-7","article-title":"Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases","volume":"12","author":"Minta","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220996_ref19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-210699","article-title":"Age-related cognitive decline and prevalence of mild cognitive impairment in the Iwaki Health Promotion Project","volume":"84","author":"Nakahata","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220996_ref20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/acn3.635","article-title":"Aging and APOE-\u025b4 are determinative factors of plasma A\u03b242 levels","volume":"5","author":"Nakamura","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-220996_ref21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-200987","article-title":"Quantitative measurement of cerebrospinal fluid amyloid-\u03b2 species by mass spectrometry","volume":"79","author":"Seino","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220996_ref22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220996_ref23","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: The universal protein knowledgebase","volume":"45","author":"The UniProt Consortium","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JAD-220996_ref24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/jcm8081236","article-title":"APOE promoter polymorphism-219T\/G is an effect modifier of the influence of APOE \u025b4 on Alzheimer\u2019s disease risk in a multiracial sample","volume":"8","author":"Choi","year":"2019","journal-title":"J Clin Med"},{"key":"10.3233\/JAD-220996_ref26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","article-title":"Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI","volume":"122","author":"Toledo","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220996_ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i07","article-title":"Multivariate and propensity score matching software with automated balance optimization: The matching package for R","volume":"42","author":"Sekhon","year":"2011","journal-title":"J Stat Softw"},{"key":"10.3233\/JAD-220996_ref28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1162\/REST_a_00318","article-title":"Genetic matching for estimating causal effects: A general multivariate matching method for achieving balance in observational studies","volume":"95","author":"Diamond","year":"2013","journal-title":"Rev Econ Stat"},{"key":"10.3233\/JAD-220996_ref30","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","article-title":"Human central nervous system (CNS) ApoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared with plasma","volume":"291","author":"Baker-Nigh","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220996_ref31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1074\/mcp.M112.018861","article-title":"Total ApoE and ApoE4 isoform assays in an Alzheimer\u2019s disease case-control study by targeted mass spectrometry (n=669): A pilot assay for methionine-containing proteotypic peptides","volume":"11","author":"Simon","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JAD-220996_ref32","doi-asserted-by":"crossref","first-page":"e89041","DOI":"10.1371\/journal.pone.0089041","article-title":"Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220996_ref33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13195-015-0105-6","article-title":"Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort","volume":"7","author":"Gupta","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220996_ref34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","article-title":"Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review","volume":"255","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-220996_ref35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","article-title":"Peripheral apoE isoform levels in cognitively normal APOE epsilon3\/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism","volume":"9","author":"Nielsen","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220996_ref36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2017.04.002","article-title":"CSF ApoE predicts clinical progression in nondemented APOEepsilon4 carriers","volume":"57","author":"van Harten","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220996_ref37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-013-1236-0","article-title":"CSF Apo-E levels associate with cognitive decline and MRI changes","volume":"127","author":"Toledo","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220996_ref38","doi-asserted-by":"crossref","first-page":"R903","DOI":"10.1152\/ajpregu.00219.2012","article-title":"Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice","volume":"303","author":"Liu","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.3233\/JAD-220996_ref39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-016-1547-z","article-title":"The role of APOE in cerebrovascular dysfunction","volume":"131","author":"Tai","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220996_ref40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.3233\/JAD-220996_ref41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-016-1580-y","article-title":"Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer\u2019s disease","volume":"132","author":"Shinohara","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220996_ref42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","article-title":"Reconstruction of the human blood\u2013brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes","volume":"26","author":"Blanchard","year":"2020","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220996_ref43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: A retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220996_ref44","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma beta-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-220996_ref45","doi-asserted-by":"crossref","first-page":"e1580","DOI":"10.1212\/WNL.0000000000009240","article-title":"Total Abeta42\/Abeta40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis","volume":"94","author":"Doecke","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-220996_ref46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220996_ref47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-220996_ref48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","article-title":"Peripheral apoE isoform levels in cognitively normal APOE \u025b3\/\u025b4 individuals are associated with regional gray matter volume and cerebral glucose metabolism","volume":"9","author":"Nielsen","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220996_ref49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/JAD-210065","article-title":"Plasma apolipoprotein E3 and glucose levels are associated in APOE \u025b3\/\u025b4 carriers","volume":"81","author":"Edlund","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220996_ref50","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaneurol.2014.2011","article-title":"Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function","volume":"71","author":"Mak","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220996_ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","article-title":"Procedures for detecting outlying observations in samples","volume":"11","author":"Grubbs","year":"1969","journal-title":"Technometrics"},{"key":"10.3233\/JAD-220996_ref53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/00401706.1972.10488930","article-title":"Rejecting outliers in factorial designs","volume":"14","author":"Stefansky","year":"1972","journal-title":"Technometrics"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:30Z","timestamp":1777370850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":50,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220996","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}